Don't miss

Replay


LATEST SHOWS

THE DEBATE

Brexit's Biggest Fan: Trump weighs in ahead of Theresa May speech (Part 1)

Read more

THE DEBATE

Brexit's Biggest Fan: Trump weighs in ahead of Theresa May speech (Part 2)

Read more

ENCORE!

Posy Simmonds: 'French women have good handbags, English women have udders'

Read more

FOCUS

Security stepped up in Italy amid terror threat

Read more

ENCORE!

Music producer Uppermost: From the courthouse to the club

Read more

TALKING EUROPE

Bulgarian president-elect hopes for lifting of Russia sanctions

Read more

TALKING EUROPE

30 years of Erasmus: Financing fun or funding employment?

Read more

THE INTERVIEW

US policy towards Putin's Russia: A new era?

Read more

THE OBSERVERS

Burmese policemen abuse Rohingya in a video, and a Malian is deported from France in handcuffs

Read more

Sanofi-Aventis withdraws anti-obesity drug from European shelves

Text by AFP

Latest update : 2008-10-24

EU authorities have suspended sales of pharmaceutical giant Sanofi-Aventis' anti-obesity drug Acomplia across the continent, due to an abnormal risk of psychiatric problems.

EU authorities suspended sales of pharmaceutical giant Sanofi-Aventis' anti-obesity drug Acomplia across the continent Thursday, the firm announced, adding that it had not ruled out a worldwide halt.

"Sales have been halted in all the pharmacies in the 18 countries of the European Union where it is distributed," a company spokesman told AFP.

Sanofi-Aventis said the European Medicines Agency (EMEA) had warned that patients taking the drug ran almost double the normal risk of psychiatric problems.

"The risks of taking Acomplia are now greater than the benefits that the drug can bring the patient according to its current guidelines," the company said, citing the EMEA.

Europe has allowed sales of Acomplia since 2006, but it has not been authorised in the United States where authorities believe it encourages suicidal thoughts, even in patients with no history of depression.

The company said it had not ruled out withdrawing the drug in the 14 non-EU countries where it is sold. It said users of the drug should consult a doctor or pharmacist.
 

Date created : 2008-10-24

COMMENT(S)